Venous thrombosis is a common disease that frequently recurs. Recurrence can be
prevented by anticoagulants, albeit at the cost of bleeding. Thus, assessment of the risk of …

Background Recurrent venous thromboembolism (VTE) is common. Current guidelines
suggest that patients with unprovoked VTE should continue anticoagulants unless they have …

Background—Predicting the risk of recurrent venous thromboembolism (VTE) in an
individual patient is often not feasible. We aimed to develop a simple risk assessment model …

Background Prediction of recurrent venous thrombosis remains a challenge in the clinic.
Objective To investigate the predictive value of coagulation factor VIII (FVIII) levels for …

Objective: To determine the predictive value of measurement of parameters of thrombin
generation for unprovoked recurrent venous thrombosis. Methods: Measurements were …

Recurrent venous thromboembolism (VTE) is associated with increased morbidity and
mortality. This risk is lowered by anticoagulation, with a large effect in the initial phase …

To determine whether fibrinolytic testing predicts recurrent venous thrombosis, we have
performed a prospective cohort study in which 303 patients with a first episode of venous …

Venous thrombosis occurs in about 1 per 1,000 individuals per year. 1, 2 It usually affects
the deep veins of the leg, but may occur in other sites, such as the upper extremities …

Background: The aim of the study was to determine the predictive value of D‐dimer
measurement for unprovoked recurrent venous thrombosis and the influence of sex, age …

ContextData on the recurrence rate of venous thrombotic events and the effect of several risk
factors, including thrombophilia, remain controversial. The potential benefit of screening for …